Trial intelligence / Profile preview

Double-blind comparison of Dysport and Botox in severe glabellar lines in women

2005-005235-96Phase 2Completed

Sponsor
Cranley Clinic
Start
Nov 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Cranley Clinic. Primary endpoint: Qualitative Rating of Glabellar Rhytids. Started Nov 2005; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

glabellar furrowing

Beyond the preview

Go deeper on 2005-005235-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005235-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call